SINOVA-M-14038 Serum Myoglobin (MYO) Quantitative Test Kit
Clinical Significance: The measurement of serum myoglobin is one of the most sensitive early indicators for the diagnosis of Acute Myocardial Infarction (AMI). However, its specificity is low, as elevated levels can also be caused by skeletal muscle injury, trauma, renal failure, and other conditions. Although a positive myoglobin test cannot confirm AMI, it is an important indicator for early exclusion of AMI diagnosis. If myoglobin is negative, myocardial infarction can be largely ruled out. It can also be used to diagnose reinfarction; if myoglobin levels rise again in combination with clinical symptoms, it suggests reinfarction or infarct extension.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
Usage Scenarios:
- Emergency Departments: For early diagnosis of Acute Myocardial Infarction (AMI) and rapid exclusion of AMI in patients presenting with chest pain.
- Cardiology Departments: For monitoring myoglobin levels to assess myocardial injury and diagnose reinfarction or infarct extension.
- Hospitals and Clinics: For evaluating patients with suspected cardiac events and differentiating between myocardial and skeletal muscle injury.
- Diagnostic Laboratories: For routine testing of serum myoglobin levels as part of cardiac health assessments.
Suitable Countries and Regions:
- Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are used for comprehensive cardiac care and early detection of myocardial infarction.
- Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving cardiac diagnostic capabilities and expanding access to modern diagnostic tools.
- Global Health Programs: International health initiatives focused on improving the diagnosis and management of cardiac conditions in low-resource settings.

